Autologous Stem Cell Transplant in Patients with Primary Central Nervous System Lymphoma: A Multicenter Analysis From the Sarah Cannon Blood Cancer Network

Background: Primary central nervous system lymphoma (PCNSL) is a rare subtype of non-Hodgkin lymphoma and carries a poor prognosis. Given the high rates of neurotoxicity associated with whole brain radiotherapy, there has been considerable interest in using high dose chemotherapy consolidation with autologous stem cell rescue (HDC-ASCT) to manage these patients.

Source: Biology of Blood and Marrow Transplantation - February 1, 2018 Category: Hematology Authors: Lisa Cantwell, Aravind Ramakrishnan, Paul J. Shaughnessy, Carlos R. Bachier, George Selby, Vikas Bhushan, Hana Safah, Morris D. Groves, Therese Dodd, Tonya Cox, Betsy Blunk, Richard Nash Source Type: research